Does Dr. JOSE APONTE RODRIGUEZ have financial conflicts of interest?

Dr. JOSE APONTE RODRIGUEZ (M.D) has received a total of $903 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $903 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JOSE APONTE RODRIGUEZ?

According to CMS Open Payments data, Dr. JOSE APONTE RODRIGUEZ received funding from GLAXOSMITHKLINE ($390), MERCK SHARP & DOHME ($134), and BIOMARIN PHARMACEUTICAL ($121).

Does Dr. JOSE APONTE RODRIGUEZ receive research grants or speaking fees?

Dr. JOSE APONTE RODRIGUEZ has received $903 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JOSE APONTE RODRIGUEZ

M.DReal-Time Hydrated

Specialty: Pediatrics, Adolescent Medicine

Practice Location: BRONX, NY 10457

NPI Number: 1679660286

LIFETIME INDUSTRY VALUE

$903

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. APONTE RODRIGUEZ is a verified Pediatrics, Adolescent Medicine practitioner based in BRONX, NY.

Between 2021 and 2025, Dr. APONTE RODRIGUEZ had an overall industry promotional and research financial footprint of $903 as recorded in the federal CMS Open Payments database.

$903 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. APONTE RODRIGUEZ's primary funding source is GLAXOSMITHKLINE, which accounts for $390 (representing 43.2% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

GLAXOSMITHKLINE

Rank 1

$390

43.2%

MERCK SHARP & DOHME

Rank 2

$134

14.9%

BIOMARIN PHARMACEUTICAL

Rank 3

$121

13.4%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.